| Name: | Azilsartan K Medoxomil Impurity 3 |
| Catalogue No. | VL252003 |
| CAS No. | 147403-52-9 |
| Molecular Formula | C26H22N4O5 |
| Molecular Weight | 470.48 |
| Status | In-stock |
| IUPAC Name | methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4- yl)methyl)-1H-benzo[d]imidazole-7-carboxylate |
| Description | Azilsartan K Medoxomil Impurity 3(CAS No: N/A) or methyl 2-ethoxy-1-((2'-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)-[1,1'-biphenyl]-4- yl)methyl)-1H-benzo[d]imidazole-7-carboxylate,it acts as to binds to AT1 receptors as an antagonist, blocking vasoconstrictor and aldosterone-secreting effects of angiotensin II. it belongs to antihypertensive class. |
| References | Jones, Jocelyn D., et al. “Azilsartan Medoxomil (Edarbi).” Pharmacy and Therapeutics, vol. 36, no. 10, 1 Oct. 2011, pp. 634–640, www.ncbi.nlm.nih.gov/pmc/articles/PMC3278144/. Accessed 28 Jan. 2022. |
